Diabetes Research and Clinical Practice

Association of tirzepatide versus Glucagon-Like Peptide-1 receptor agonists with oral and periodontal outcomes in patients with type 2 Diabetes: A Global propensity Score-Matched cohort study

By Cheng-Yun Tu, Hui-Ling Chen, Yu-Hsien Wu, Ming-Ju Wu

Figure 1 from Diabetes Research and Clinical Practice — Figure 1. Tu et al.

Cohort study of 97,993 peopleInterventions

1 year, declared ties to: Pfizer, Janssen, Novartis and 2 more

The paper

Cheng-Yun Tu, Hui-Ling Chen, Yu-Hsien Wu, Ming-Ju Wu

Taichung Veterans General Hospital; National Yang Ming Chiao Tung University

Diabetes Research and Clinical Practice, 20 Sep 2026

doi.org/10.1016/j.diabres.2026.113573 PubMed 42764072

Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Drug Design, Development and Therapy5 Oct 2026
GLP-1 agonists linked to lower dementia risk after COVID-19
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes